NCT01554683View on ClinicalTrials.gov

Seizure Activity in Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Alzheimer's DiseaseSeizures
Interventions
DRUG

Low/High/Placebo Dose Keppra (Levetiracetam)

Low Dose (2.5 mg/kg) High Dose (7.5 mg/kg) Placebo (Saline)

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01554683 - Seizure Activity in Alzheimer's Disease | Biotech Hunter | Biotech Hunter